NCT03611556 2023-10-03
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
MedImmune LLC
Phase 1/2 Completed
MedImmune LLC
VA Office of Research and Development
University of Chicago
Eli Lilly and Company
Eli Lilly and Company
Washington University School of Medicine
Sanofi